193 related articles for article (PubMed ID: 15959879)
1. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
Ilkhanoff L; Lewis JD; Hennessy S; Berlin JA; Kimmel SE
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):513-22. PubMed ID: 15959879
[TBL] [Abstract][Full Text] [Related]
2. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL
J Am Coll Cardiol; 2004 Mar; 43(6):985-90. PubMed ID: 15028354
[TBL] [Abstract][Full Text] [Related]
3. Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.
Hochain P; Berkelmans I; Czernichow P; Duhamel C; Tranvouez JL; Lerebours E; Colin R
Eur J Gastroenterol Hepatol; 1995 May; 7(5):419-26. PubMed ID: 7614104
[TBL] [Abstract][Full Text] [Related]
4. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
5. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Lewis JD; Kimmel SE; Localio AR; Metz DC; Farrar JT; Nessel L; Brensinger C; McGibney K; Strom BL
Gastroenterology; 2005 Dec; 129(6):1865-74. PubMed ID: 16344055
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study.
Ray WA; Stein CM; Hall K; Daugherty JR; Griffin MR
Lancet; 2002 Jan; 359(9301):118-23. PubMed ID: 11809254
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of medication recall using medication pictures and lists in telephone interviews.
Kimmel SE; Lewis JD; Jaskowiak J; Kishel L; Hennessy S
Pharmacoepidemiol Drug Saf; 2003; 12(1):1-8. PubMed ID: 12622055
[TBL] [Abstract][Full Text] [Related]
8. Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure.
Lewis JD; Strom BL; Kimmel SE; Farrar J; Metz DC; Brensinger C; Nessel L; Localio AR
Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):39-45. PubMed ID: 16136614
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs.
Kelly JP; Coogan P; Strom BL; Rosenberg L
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):322-7. PubMed ID: 18041807
[TBL] [Abstract][Full Text] [Related]
10. Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular events.
Cheng JW
Ann Pharmacother; 2006 Oct; 40(10):1785-96. PubMed ID: 16985093
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; González-Pérez A
BMC Med; 2005 Nov; 3():17. PubMed ID: 16316472
[TBL] [Abstract][Full Text] [Related]
12. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
Rahme E; Nedjar H; Bizzi A; Morin S
Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
[TBL] [Abstract][Full Text] [Related]
13. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rahme E; Nedjar H
Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
Velentgas P; West W; Cannuscio CC; Watson DJ; Walker AM
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):641-52. PubMed ID: 16392153
[TBL] [Abstract][Full Text] [Related]
15. Potential bias caused by control selection in secondary data analysis: nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke.
Choi NK; Hahn S; Yoon BW; Park BJ
Pharmacoepidemiol Drug Saf; 2010 Jun; 19(6):604-9. PubMed ID: 20049849
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.
Friis S; Poulsen AH; Sørensen HT; Tjønneland A; Overvad K; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
Cancer Causes Control; 2009 Jul; 20(5):731-40. PubMed ID: 19122977
[TBL] [Abstract][Full Text] [Related]
17. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.
Helin-Salmivaara A; Virtanen A; Vesalainen R; Grönroos JM; Klaukka T; Idänpään-Heikkilä JE; Huupponen R
Eur Heart J; 2006 Jul; 27(14):1657-63. PubMed ID: 16731535
[TBL] [Abstract][Full Text] [Related]
18. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
20. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.
García Rodríguez LA; Tacconelli S; Patrignani P
J Am Coll Cardiol; 2008 Nov; 52(20):1628-36. PubMed ID: 18992652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
